Chemical Structure : SB-525334
CAS No.: 356559-20-1
货号: PC-42858Not For Human Use, Lab Use Only.
SB-525334 (SB525334) is a potent and selective inhibitor of TGF-β1 receptor (ALK5) inhibitor with IC50 of 14,5 nM, 4-fold less potent against ALK4 and inactive for ALK2, ALK3, and ALK6 (IC50>10 uM).
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 10 mg | ¥780 | In stock | |
| 25 mg | ¥1380 | In stock | |
| 50 mg | ¥2180 | In stock | |
| 100 mg | Get quote |
大包装,大折扣!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
SB-525334 (SB525334) is a potent and selective inhibitor of TGF-β1 receptor (ALK5) inhibitor with IC50 of 14,5 nM, 4-fold less potent against ALK4 and inactive for ALK2, ALK3, and ALK6 (IC50>10 uM).
SB 525334 blocks TGFβ1-induced phosphorylation and nuclear translocation of Smad2/3 in renal proximal tubule cells and inhibits TGFβ1-induced increases in PAI-1 and procollagen α1 mRNA expression in A498 renal epithelial carcinoma cells at 1 uM.
SB 525334 significantly inhibits PAN-induced proteinuria in rat model of nephritis-induced renal fibrosis.
| 分子量 | 343.4249 | |
| 分子式 | C21H21N5 | |
| 外观性状 | Solid | |
| 储存条件 |
|
|
| Solubility |
DMSO: ≥ 46 mg/mL |
|
| Chemical Name/SMILES |
Quinoxaline, 6-[2-(1,1-dimethylethyl)-5-(6-methyl-2-pyridinyl)-1H-imidazol-4-yl]- |
|
1. Grygielko ET, et al. J Pharmacol Exp Ther. 2005 Jun;313(3):943-51.
2. Laping NJ, et al. Clin Cancer Res. 2007 May 15;13(10):3087-99.
3. Thomas M, et al. Am J Pathol. 2009 Feb;174(2):380-9.
4. Kim YJ, et al. Anticancer Res. 2012 Mar;32(3):799-806.
备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright